A next-generation GMMA-based vaccine candidate to fight shigellosis.
Journal Information
Full Title: NPJ Vaccines
Abbreviation: NPJ Vaccines
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests All authors are, or were when the study was conducted, employees of the GSK group of companies."
Funding Disclosure
Evidence found in paper:
"We thank all GVGH employees for their valuable contributions and advice. We are grateful to GSK and Toscana Life Sciences animal facilities for their invaluable support in running the animal experiments. This work was sponsored by GlaxoSmithKline Biologicals SA. This project was partially funded by a grant from the Bill and Melinda Gates Foundation (grant number INV-006482)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025